Open Access
- 6 January 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1091
Abstract
The liver is a secondary and often collateral target of COVID-19 disease but can lead to important consequences. COVID-19 might directly cause a high number of complications in patients with pre-existing chronic liver disease, increasing their risk of hepatic decompensation. Moreover, it also determines indirect consequences in the management of patients with liver disease, especially in those suffering from decompensated cirrhosis and HCC, as well as in the execution of their follow-up and the availability of all therapeutic possibilities. Liver imaging in COVID-19 patients proved to be highly nonspecific, but it can still be useful for identifying the complications that derive from the infection. Moreover, the recent implementation of telemedicine constitutes a possible solution to both the physical distancing and the re-organizational difficulties arising from the pandemic. The present review aims to encompass the currently hypothesized pathophysiological mechanisms of liver injury in patients with COVID-19 mediated by both the direct invasion of the virus and its indirect effects and analyze the consequence of the pandemic in patients with chronic liver disease and liver tumors, with particular regard to the management strategies that have been implemented to face this worldwide emergency and that can be further improved.Keywords
This publication has 225 references indexed in Scilit:
- Establishment of a Regional Virtual Tumor Board Program to Improve the Process of Care for Patients With Hepatocellular CarcinomaJournal of Oncology Practice, 2015
- BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20‐year survey by the Italian Liver Cancer groupLiver International, 2014
- Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitisAnnals of Hepatology, 2013
- Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of CirrhosisGastroenterology, 2013
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature, 2013
- Immune Dysfunction and Infections in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2011
- Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2Gut, 2005
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Letales Leberversagen nach Corticosteroidtherapie bei Hepatitis-B-Carrier-StatusDMW - Deutsche Medizinische Wochenschrift, 1999